Abstract:Objectives: Osteoarthritis (OA) is the most common joint disease in the world. Among the many risk factors for OA, aging is one of the most critical factors. The treatment with senop-associated secretory phenotype (SASP) is one of the important, promising anti-aging strategies at present. Pterostilbene (PTE) is a trans-stilbene compound with anti-tumor, anti-oxidation, anti-inflammatory, and anti-aging pharmacologic activities. The purpose of this study is to explore the therapeutic effects of PTE on articular chondrocyte senescence and OA and its related mechanisms. Methods: Male Sprague-Dawley rats were operated on with transection of the anterior cruciate ligament (ACLT) and a destabilized medial meniscus (DMM) surgery to establish the OA model and then injected intraperitoneally with PTE (20 mg/kg) for 5 weeks. Finally, rats were sacrificed and knee joints were collected for histologic analysis. Rat chondrocytes were stimulated with interleukin-1β (IL-1β) with or without PTE treatment. The therapeutic effects of PTE and related mechanisms were investigated by examining and analyzing relative markers through senescence-associated β-galactosidase (SA-β-Gal) assay, cell cycle, qRT-PCR, western blot, bioinformatic analysis, immunofluorescence, and molecular modeling. Results: With in vivo experiments, PTE can significantly reduce the Mankin scores and OARSI scores of the knee joint in ACLT+DMM OA model rats and reduce the interleukin-6 (IL-6) level in the knee lavage fluid. Immunohistochemical staining showed that compared to the OA group, the PTE treatment group had significantly increased expression of collagen type II in articular cartilage, and significantly decreased matrix metalloproteinase 13 (MMP-13) and IL-6, the main SASP proteins, and had expression of p16 and p21, markers of aging in chondrocytes. In vitro, PTE reduced the ratio of SA-β-Gal positive chondrocytes and G0-G1 phase chondrocytes in IL-1β-induced rat chondrocytes. PTE significantly inhibited the expression of MMP-13, IL-6, thrombospondin motif 5 (ADAMTS5), p16, and p21, and significantly increased the expression of collagen type II. Bioassay and subsequent western blot showed that PTE significantly inhibited the activation of PI3K/AKT and NF-κB signaling pathways. The results of molecular docking experiments showed that PTE could bind closely to the sites of PI3K protein, thereby inhibiting the phosphorylation of PI3K. Conclusions: The experimental results indicate that PTE plays an anti-chondrocyte senescence role in the treatment of OA by inhibiting the PI3K/AKT/NF-κB signaling pathway and reducing expression of SASP.

TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis

circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Therapeutic Potential of POU3F3, a Novel Long Non-coding RNA, Alleviates the Pathogenesis of Osteoarthritis by Regulating the miR-29a-3p/FOXO3 Axis

LONP1 Downregulation with Ageing Contributes to Osteoarthritis Via Mitochondrial Dysfunction.

miR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18

Up-regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis.

Polydeoxyribonucleotide ameliorates IL-1β-induced impairment of chondrogenic differentiation in human bone marrow-derived mesenchymal stem cells

MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by directly targeting ZMPSTE24

Pin1-mediated regulation of articular cartilage stem/progenitor cell aging

Inhibition of Cpt1a alleviates oxidative stress-induced chondrocyte senescence via regulating mitochondrial dysfunction and activating mitophagy

FOXP1 Controls Mesenchymal Stem Cell Commitment and Senescence During Skeletal Aging

Senomorphic agent pterostilbene ameliorates osteoarthritis through the PI3K/AKT/NF-κB axis: an in vitro and in vivo study

TUG1 Knockdown Promoted Viability and Inhibited Apoptosis and Cartilage ECM Degradation in Chondrocytes Via the Mir-17-5p/fut1 Pathway in Osteoarthritis.

Downregulation of the RNA-binding protein PUM2 facilitates MSC-driven bone regeneration and prevents OVX-induced bone loss

piRNA mmu_piR_037459 suppression alleviated the degeneration of chondrocyte and cartilage

Knockdown of PRMT1 Suppresses IL-1β-induced Cartilage Degradation and Inflammatory Responses in Human Chondrocytes Through Gli1-mediated Hedgehog Signaling Pathway

Down-regulation of LRRc17 secreted by BMSCs alleviates age-related bone aging through autophagy enchancement

PUM2 promoted osteoarthritis progression through PTEN‐mediated chondrocyte ferroptosis by facilitating NEDD4 mRNA degradation

Long Non-Coding RNA PVT1, a Molecular Sponge for Mir-149, Contributes Aberrant Metabolic Dysfunction and Inflammation in IL-1β-simulated Osteoarthritic Chondrocytes.

Inhibition of Mir-490-5p Promotes Human Adipose-Derived Stem Cells Chondrogenesis and Protects Chondrocytes Via the PITPNM1/PI3K/AKT Axis